You are here

Structural & Congenital Heart Disease


The self-expanding Centera transcatheter heart valve has received CE mark approval, device manufacturer Edwards Lifesciences announced Feb. 15.

Survivors of childhood heart defects are more likely than the general population to develop dementia, including at earlier ages, researchers reported Feb. 12 in Circulation.

US News & World Report issued their rankings for the top 10 hospitals for pediatric cardiology and heart surgery in the country.

New research published in the Journal of the American Medical Association suggests a patent foramen ovale (PFO), colloquially known as a hole in the heart, can double the risk of stroke within 30 days of non-cardiac surgery.

The LOTUS Edge Aortic Valve System will not be available in Europe or the U.S. until at least 2019, Boston Scientific CEO Mike Mahoney said during a Feb. 1 conference call with investors.


Recent Headlines

Linking high volume to better outcomes in TAVR

If you want something done well, ask a busy person. That was one of my dad’s adages over the years. The same is true in healthcare, as many studies have found that volume—busy-ness—and quality in medicine go hand in hand.

High-functioning TAVR hospitals experience fewer readmissions

Increasing productivity among cardiologists performing transcatheter aortic valve replacements (TAVR) could help lower readmissions, according to a new study that found a correlation between high-volume TAVR hospitals and lower 30-day readmission rates.

Narrative journaling could boost cardiac health after divorce

Stress from a divorce could harm heart health, but a new study from researchers at the University of Arizona has found that narrative journaling could help boost the cardiovascular system.

Athletic training by children improves right ventricle efficiency

Children’s sports have continued to become more competitive in recent decades, with athletes taking on more intense training at earlier ages. A research team from Italy examined the impact of endurance on cardiac remodeling, specifically in the heart’s right ventricle (RV).

Researchers ID enzyme related to smoking, heart disease

Smoking is known to increase the risk of heart disease, but certain patients carrying a particular gene may be at an even higher risk, according to a new study from Columbia University in New York.

Enzyme elimination method in mice improves healing after heart attack

A team of researchers at the University of Alabama at Birmingham (UAB) has found a way to improve healing and reduce inflammation after a heart attack using mouse models.

Mortality risk associated with infective endocarditis decreases in New York, California

From 1998 through 2013, the standardized incidence of infective endocarditis in New York and California remained stable between 7.6 and 7.8 cases per 100,000 persons each year, according to a retrospective database analysis. During that same period, the adjusted mortality risk related to infective endocarditis decreased 2 percent per year.

AATS provides updated guidelines for managing ischemic mitral regurgitation

The American Association for Thoracic Surgery (AATS) released updated evidence-based guidelines for managing ischemic mitral regurgitation.

Research finds azithromycin not linked to arrhythmias

Azithromycin, an antibiotic commonly used to treat bacterial infections has been associated with disrupting the heart’s normal rhythm, but a new study has debunked that theory, showing that the drug doesn’t cause ventricular arrhythmias.

Multidisciplinary, team approach benefits TAVR patients

A recent survey from the Society of Thoracic Surgeons (STS) found that 77.5 percent of cardiac surgeons were involved in TAVR procedures as part of multidisciplinary heart teams.